Managers / Q3 2024 · view latest →
PenderFund Capital Management Ltd.
CIK 0001706164 · SUITE 1830, 1066 W. HASTINGS STREET, VANCOUVER, A1, V6E 3X2 · 6046881511
Reported Value
$434M
Q3 2024
Positions
137
Filings on Record
32
2019–present window
Filed
Nov 14, 2024
original filing
Summary
Penderfund Capital Management Ltd. reported $434M in U.S.-listed holdings across 137 positions for Q3 2024.
Its largest position, Esperion Therapeutics Inc Ne, represents 12.2% of the portfolio.
Compared with Q2 2024, the fund opened 54 new positions and exited 43.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
Composition data arrives with ticker enrichment.
Quarter-over-Quarter Changes full breakdown →
Holdings — Q3 2024
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $639M | 253 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $635M | 219 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $593M | 207 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $367M | 142 | Aug 14, 2025 | RESTATEMENT | changes · EDGAR ↗ |
| Q1 2025 | $514M | 142 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $465M | 129 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $434M | 137 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $364M | 126 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $378M | 116 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $307M | 105 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $333,695 | 112 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $321,680 | 114 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $318,441 | 130 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $335M | 140 | Feb 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $320M | 179 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $362M | 179 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $408M | 172 | May 17, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $441M | 157 | Feb 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $383M | 140 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $427M | 88 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $412M | 92 | May 10, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $393M | 81 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $360M | 70 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $370M | 71 | Aug 17, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $320M | 57 | Apr 27, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $356M | 56 | Feb 5, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $297M | 64 | Oct 29, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $280M | 67 | Jul 31, 2019 | RESTATEMENT | changes · EDGAR ↗ |
| Q1 2019 | $344M | 69 | Apr 23, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $302M | 70 | Jan 24, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.